MedTechnology

Does the U.S. Exit from WHO Redefine Global Health Governance? Washington Completes Historic Withdrawal

23 January 2026 Executive Summary The United States has formally completed its withdrawal from the World Health Organization…

ByByAnuja Singh Jan 24, 2026

Does the U.S. Exit from WHO Redefine Global Health Governance? Washington Completes Historic Withdrawal

23 January 2026 Executive Summary The United States has formally completed its withdrawal from the World Health Organization…

ByByAnuja Singh Jan 24, 2026

Is JPM 2026 the Moment Biopharma Finally Reset Its Strategy?

January 2026 — San Francisco | Global — The 44th Annual J.P. Morgan Healthcare Conference (JPM 2026) marked…

ByByAnuja Singh Jan 23, 2026

Is AI Now Shaping the Future of Biopharma R&D — and Who’s Leading the Transformation?

Executive Summary A recent Endpoints Signal Pulse Report reveals that half of biopharma professionals now consider themselves heavy…

ByByAnuja Singh Jan 2, 2026
Image Not Found

Is Insilico’s AI Drug Engine “Einstein” Turning China into the Global AI–Pharma Hub?

Insilico Medicine’s AI‑driven drug discovery platform, Pharma.AI “Einstein,” is scaling fast in China, with a major expansion of…

ByByAnuja Singh Mar 4, 2026

Biotech Licensing Soars to $137B in 2025 – China Now Leads the Licensing Race

The global biotech licensing market hit a record $137 billion in 2025, and 2026 is on track to…

ByByAnuja Singh Mar 4, 2026
Scroll to Top